For example, rottlerin suppressed the expression of LRP6 (low density lipoprotein receptor-related protein-6) and inhibited Wnt/β-catenin and mTORC1 signaling pathway in prostate and breast cancer cells [25]. This evidence concerns the gene LRP6 and breast carcinoma.